Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

MYC + diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

Wendy Cuccuini, Josette Briere, Nicolas Mounier, Hans-Ullrich Voelker, Andreas Rosenwald, Christer Sundstrom, Sergio Cogliatti, Edouard Hirchaud, Loic Ysebaert, Dominique Bron, Jean Soulier, Philippe Gaulard, Remi Houlgatte, Christian Gisselbrecht, Catherine Thieblemont

Blood (2012) 119 (20): 4619–4624.

https://doi.org/10.1182/blood-2012-01-406033

Published: 2012

Journal Articles

MYC + Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report

Wendy Cuccuini, Josette Briere, Nicolas Mounier, MD, PhD, Hans-Ullrich Voelker, Andreas Rosenwald, MD, Christer Sundstrom, MD, PhD, Sergio Cogliatti, Dominique Bron, MD, Edouard Hirchaud, Jean Soulier, MD, Philippe Gaulard, MD, Remi Houlgatte, C. Gisselbrecht, MD, Catherine Thieblemont, MD

Blood (2011) 118 (21): 594.

https://doi.org/10.1182/blood.V118.21.594.594

Published: 2011

Journal Articles

Prognostic Impact of Germinal Center (GC)/ Activated B-Cell (ABC) Classification Analysed by Immunochemistry, FISH Analysis and GEP, In Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The Bio-CORAL Study

Catherine Thieblemont, MD, Josette Briere, MD, Nicolas Mounier, Hans-Ullrich Voelker, Wendy Cuccini, Edouard Hirchaud, Andreas Rosenwald, Andrew Jack, PhD, MB, Christer Sundstrom, MD, PhD, Sergio Cogliatti, Phlippe Trougouboff, Ludmila Boudova, Jean Soulier, Remi Houlgatte, Norbert Schmitz, MD, Philippe Gaulard, Christian Gisselbrecht, MD

Blood (2010) 116 (21): 993.

https://doi.org/10.1182/blood.V116.21.993.993

Published: 2010

Journal Articles

Farnesyltransferase Inhibitor Tipifarnib (Zarnestra) in Refractory Mantle Cell Lymphoma (MCL): A Therapeutic Target Only for Specific Patients Categorized by the 2-Gene Classifier for Predictive Response to Tipifarnib.

Delphine Rolland, Vincent Ribrag, Corinne Haioun, Herve Ghesquieres, MD, Fabrice Jardin, Reda Bouabdallah, Patricia Franchi, Josette Briere, Eric De Kerviler, Catherine Chassagne-Clement, Mitch Raponi, PhD, Remi Houlgatte, Jean-Philippe Jais, Catherine Thieblemont

Blood (2008) 112 (11): 1561.

https://doi.org/10.1182/blood.V112.11.1561.1561

Published: 2008

Journal Articles

Indolent Mantle Cell Lymphoma (MCL): A Retrospective Detailed Clinical and Morphological Analysis of 21 Patients, with Histological, Cytological, Cytogenetic, Interphase Genetic, Immunoglobulin Gene, and Gene Expression Profiling Analysis.

Catherine Thieblemont, Remi Houlgatte, Pascale Felman, Alexandra Traverse-glehen, Lucile Baseggio, Delphine Rolland, Evelyne Callet-Bauchu, Gilles Salles, Francoise Berger, Bertrand Coiffier

Blood (2008) 112 (11): 1780.

https://doi.org/10.1182/blood.V112.11.1780.1780

Published: 2008

Journal Articles

Multiple Secondary Genetic Events Inducing Histologic Progression (HP) of Non-MALT Marginal Zone Lymphoma (MZL): An Integrated Genomic Analysis of Genome-Wide Copy-Number-Changes (CNC) and Transcriptomic Data.

Blood (2008) 112 (11): 1198.

https://doi.org/10.1182/blood.V112.11.1198.1198

Published: 2008

Journal Articles

SELDI-TOF Identifies Specific Protein Patterns in Small Lymphocytic Lymphoma, Marginal Zone Lymphoma and Mantle Cell Lymphoma.

Delphine Rolland, Ali Bouamrami, Benoit Ballester, Samuel Grangeaud, Marie Arlotto, Aurelie Paret, Francoise Berger, Pascale Felman, Evelyne Callet-Bauchu, Bertrand Coiffier, Remi Houlgatte, Francois Berger, Catherine Thieblemont

Blood (2005) 106 (11): 988.

https://doi.org/10.1182/blood.V106.11.988.988

Published: 2005

NARROW

MYC + diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

MYC + Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report

Prognostic Impact of Germinal Center (GC)/ Activated B-Cell (ABC) Classification Analysed by Immunochemistry, FISH Analysis and GEP, In Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The Bio-CORAL Study

Farnesyltransferase Inhibitor Tipifarnib (Zarnestra) in Refractory Mantle Cell Lymphoma (MCL): A Therapeutic Target Only for Specific Patients Categorized by the 2-Gene Classifier for Predictive Response to Tipifarnib.

Indolent Mantle Cell Lymphoma (MCL): A Retrospective Detailed Clinical and Morphological Analysis of 21 Patients, with Histological, Cytological, Cytogenetic, Interphase Genetic, Immunoglobulin Gene, and Gene Expression Profiling Analysis.

Multiple Secondary Genetic Events Inducing Histologic Progression (HP) of Non-MALT Marginal Zone Lymphoma (MZL): An Integrated Genomic Analysis of Genome-Wide Copy-Number-Changes (CNC) and Transcriptomic Data.

SELDI-TOF Identifies Specific Protein Patterns in Small Lymphocytic Lymphoma, Marginal Zone Lymphoma and Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

MYC + diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

MYC + Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report

Prognostic Impact of Germinal Center (GC)/ Activated B-Cell (ABC) Classification Analysed by Immunochemistry, FISH Analysis and GEP, In Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The Bio-CORAL Study

Farnesyltransferase Inhibitor Tipifarnib (Zarnestra) in Refractory Mantle Cell Lymphoma (MCL): A Therapeutic Target Only for Specific Patients Categorized by the 2-Gene Classifier for Predictive Response to Tipifarnib.

Indolent Mantle Cell Lymphoma (MCL): A Retrospective Detailed Clinical and Morphological Analysis of 21 Patients, with Histological, Cytological, Cytogenetic, Interphase Genetic, Immunoglobulin Gene, and Gene Expression Profiling Analysis.

Multiple Secondary Genetic Events Inducing Histologic Progression (HP) of Non-MALT Marginal Zone Lymphoma (MZL): An Integrated Genomic Analysis of Genome-Wide Copy-Number-Changes (CNC) and Transcriptomic Data.

SELDI-TOF Identifies Specific Protein Patterns in Small Lymphocytic Lymphoma, Marginal Zone Lymphoma and Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only